28 results match your criteria: "GRIAC-Groningen Research Institute for Asthma and COPD[Affiliation]"
Am J Physiol Lung Cell Mol Physiol
February 2015
University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, GRIAC- Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands;
Chronic exposure to farm environments is a risk factor for nonallergic lung disease. In contrast to allergic asthma, in which type 2 helper T cell (Th2) activation is dominant, exposure to farm dust extracts (FDE) induces Th1/Th17 lung inflammation, associated with neutrophil infiltration. Macrophage influx is a common feature of both types of lung inflammation, allergic and nonallergic.
View Article and Find Full Text PDFThorax
July 2014
Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, GRIAC-Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands.
Rationale: A low prevalence of asthma and atopy has been shown in farmers and agricultural workers. However, in these workers, a higher prevalence of respiratory symptoms has been reported, in which T helper 1 (Th1) and/or Th17 responses may play a role.
Aim: We investigated the effect of exposure to dust extracts (DEs) from different farms on airway inflammation and T-cell polarisation in a mouse model and assessed T-cell polarisation in agricultural workers from the same farms.
Int J Chron Obstruct Pulmon Dis
April 2014
Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands ; GRIAC (Groningen Research Institute for Asthma and COPD), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Patients with chronic obstructive pulmonary disease (COPD) present with a variety of symptoms that significantly impair health-related quality of life. Despite this, COPD treatment and its management are mainly based on lung function assessments. There is increasing evidence that conventional lung function measures alone do not correlate well with COPD symptoms and their associated impact on patients' everyday lives.
View Article and Find Full Text PDF